Epigenetic Drugs: Team Players in Combo Therapies
Scientists May Be Better Able to Destroy Tumors and Possibly Reverse CNS Decline
Cell Therapy Manufacturing: All Signs Point to Commercialization
As Milestones Are Reached, Best Practices Will Become Less Hazy
Bioelectricity, New Peer Reviewed Journal Announced
An Outstanding and Influential Foundation for a Dynamic, Emerging Field
Biomaterials Could Extend the Success of Immunotherapies
A New Review Paper Encourages Clinicians to Pull Ideas from the Desks of Engineers
For full access to this article login to GEN Select now.
Avoiding Costly Errors in Bioassay Development
Developers Have a Range of Options When Optimizing Bioassays for Biologics
- A good bioassay, like a good marriage, joins two partners in a bond and is mutually beneficial. In the case of bioassays, optimal design and development and accurate statistical analysis comprise a lasting partnership. At the Cambridge Healthtech Institutes’s fifth annual Optimizing Bioassays for Biologics conference, held in ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.